Resonant Capital Advisors »

Intellia Therapeutics shares owned by Resonant Capital Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Resonant Capital Advisors from 13F filings

Historical chart of Resonant Capital Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Resonant Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Resonant Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 41k 30.49
2023-09-30 $989k 31k 31.62

More positions owned by Resonant Capital Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Etf Ser Solutions Distillate Us (DSTL)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Ultra Sht Muncpl (JMST)
Ishares U S Etf Tr Blackrock Short (MEAR)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Schwab Fdt Us Sc (FNDA)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Resonant Capital Advisors

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Wellington Management Company
Federated Investors
T. Rowe Price Associates
Alliancebernstein
Citadel Advisors
Rokos Capital Management
Casdin Capital
Dimensional Fund Advisors
Chevy Chase Trust Holdings
Marshall Wace
Goldman Sachs Group

View all funds holding Intellia Therapeutics